Table 1 Demographic and clinical information of colorectal cancer patients.
From: Intratumor heterogeneity inferred from targeted deep sequencing as a prognostic indicator
Characteristics | Number of patients (n = 304) |
|---|---|
Age, median (years) | 54.5 |
Gender, n (%) | |
  Male | 186 (61.2%) |
  Female | 118 (38.8%) |
CEA, n (%) | |
  <5 ng/ml | 173 (56.9%) |
  ≥5 ng/ml | 120 (39.5%) |
  Unknown | 11 (3.6%) |
Location of primary tumor, n (%) | |
  Colon | 201 (66.1%) |
  Rectum | 103 (33.9%) |
Stage, n (%) | |
  I | 10 (3.3%) |
  II | 30 (9.9%) |
  III | 125 (41.1%) |
  IV | 139 (45.7%) |
Cell type, n (%) | |
  WD/MD | 253 (83.2%) |
  PD/MUC/SRC | 51 (16.8%) |
Lymphatic invasion, n (%) | |
  Yes | 170 (55.9%) |
  No | 124 (40.8%) |
  Unknown | 10 (3.3%) |
Vascular invasion, n (%) | |
  Yes | 135 (44.4%) |
  No | 158 (52.0%) |
  Unknown | 11 (3.6%) |
Perineural invation, n (%) | |
  Yes | 117 (38.5%) |
  No | 171 (56.2%) |
  Unknown | 16 (5.3%) |
Tumor budding, n (%) | |
  Yes | 189 (62.2%) |
  No | 73 (24.0%) |
  Unknown | 42 (13.8%) |
Adjuvant treatment, n (%) | |
  Yes | 294 (96.7%) |
  No | 10 (3.3%) |
